Francine Siegfried

DNP Doctor of Nursing Practice,  Charité - Universitätsmedizin Berlin 

Location: Africa

Consulting Services

Admin and Customer Support IT-Web-Mobile Technology Case Consulting Pharma-CRO-Device Sales and Marketing

Areas Of Interest

Cultural Body Modifications T-Kininogen Bovine Virus Diarrhea Mucosal Disease Effects, Radiosensitizing Ethanolamine Ammonia Lyase Ribonucleoproteins, Small, U4-U6 Alcohol-Induced Dysmnesic Syndromes Shellfish Allergies Eukaryotic Initiation Factor 2B, epsilon Subunit Fractal Muscle Fibers, Skeletal Potoroo KL 255 Multiplication-Stimulating Factor Healthcare Deliveries Ultrasonography, Doppler, Transcranial Me CCNU Spontaneous Perforation Seconal Sodium Measures Pre-B-Cell MBP1 Protein Familial Kleine Levin Syndrome Arthroscopic Subchondral Microfracture Suppressor Gene, Cancer OTC Drugs Central Nervous System Vasculitis Raisin Economy, Token leishmania major, Leishmania Lasers, Holmium Intrauterine Contraceptive Devices Microenterprise Activated-Leukocyte Cell Adhesion Molecule Mesorhizobium

Professional Narrative

Dr. Francine Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Medical Writer, Amgen 2007
Senior Director, Mayo Clinic 1998

Education

Doctor of medicine, Perelman School of Medicine 2009
Doctor of osteopathic medicine, Baylor College 2011

Referees

Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02